Returns and refunds are honored even on opened products
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
Ibutamoren, while effective, can cause increased appetite, joint pain, and potential insulin resistance, which may impact body weight
Stronger satiety effects typically appear after stepping up to 0.5-1.0 mg/week
Legal supply is restricted to approved clinical trials
Extremely rare occurrences of ribose-5-phosphate isomerase and transaldolase deficiency have also been documented